Global Prostaglandin Market Size study, by Type (Human Prostaglandin, Veterinary Prostaglandin), Application (Cardiovascular, Digestive, Gynecological & Obstetrical, Ophthalmologic, Others) and Regional Forecasts 2019-2026


Report ID : RC-43986 Category : Healthcare
Published Date : Jun-19 Pages : 200 Format : PDF
Global Prostaglandin Market is valued approximately USD 461.30 million in 2018 and is anticipated to grow with a healthy growth rate of more than 4.84% over the forecast period 2019-2026. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax. Increasing incidences of digestive problem and rising prevalence of cardiovascular diseases are the factors that contributing towards growth of global Prostaglandin market. Further, prostaglandins help in increasing concentration of cAMP, calcium ions and activate G proteins inside the cells, all of which are involved in the transfer of energy and inflammatory signaling process which is the factor that regulates their demand across various regions. However, high cost of treatment and several side-effects associated with its over-dose such as migraines and decrease the ability to fight with cancer are the factors that anticipated to restrain the market growth during the forecast period. The regional analysis of global Prostaglandin market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. 

Major market player included in this report are:
CEPIA
Johnson Matthey
Pfizer
Cayman Chemical
EMD Millipore
Yonsung Fine Chemicals
Everlight Chemical
Piramal Enterprises
Bio-Techne Corporation
Mironova Labs
Chirogate
 
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: 

By Type:

Human Prostaglandin
Veterinary Prostaglandin

By Application:

Cardiovascular
Digestive
Gynecological & Obstetrical
Ophthalmologic
Others
 
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year ? 2016, 2017
Base year ? 2018
Forecast period ? 2019 to 2026

Target Audience of the Global Prostaglandin Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
TABLE OF CONTENTS

Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
1.3.1.	Prostaglandin Market, by Type, 2016-2026 (USD Million)
1.3.2.	Prostaglandin Market, by Application, 2016-2026 (USD Million)
1.3.3.	Prostaglandin Market, by Region, 2016-2026 (USD Million)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Prostaglandin Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Prostaglandin Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Prostaglandin Market Industry Analysis
4.1.	Porter?s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter?s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Prostaglandin Market, by Type
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Prostaglandin Market, Sub Segment Analysis
5.3.1.	Human Prostaglandin
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Million)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.2.	Veterinary Prostaglandin
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Million)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 6.	Global Prostaglandin Market, by Application
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Prostaglandin Market, Sub Segment Analysis
6.3.1.	Cardiovascular
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Million)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.2.	Digestive
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Million)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.3.	Gynecological & Obstetrical 
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Million)
6.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.4.	Ophthalmologic
6.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Million)
6.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.5.	Others
6.3.5.1.	Market estimates & forecasts, 2016-2026 (USD Million)
6.3.5.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 7.	Global Prostaglandin Market, by Regional Analysis
7.1.	Prostaglandin Market, Regional Market Snapshot (2016-2026)
7.2.	North America Prostaglandin Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.2.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.2.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.2.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.2.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.3.	Europe Prostaglandin Market Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.3.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.2.	Germany
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.3.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)      
7.3.3.	Rest of Europe
7.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.3.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.3.3.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.4.	Asia Prostaglandin Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.4.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.4.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.4.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.4.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.4.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.4.3.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.4.4.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.4.4.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.5.	Latin America Prostaglandin Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.5.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.5.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.5.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.5.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.6.	Rest of The World 
7.6.1.	South America
7.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.6.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.6.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
7.6.2.	Middle East and Africa
7.6.2.1.	Market estimates & forecasts, 2016-2026 (USD Million)
7.6.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Million) 
7.6.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Million)  
Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	CEPIA
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	Product Summary
8.3.1.4.	Recent Developments
8.3.2.	Johnson Matthey
8.3.3.	Pfizer
8.3.4.	Cayman Chemical
8.3.5.	EMD Millipore
8.3.6.	Yonsung Fine Chemicals
8.3.7.	Everlight Chemical
8.3.8.	Piramal Enterprises
8.3.9.	Bio-Techne Corporation
8.3.10.	Mironova Labs
8.3.11.	Chirogate 
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption

Sidebar Menu